“I smoked it and I felt the disease stop. I flew home that way, and my husband had a nervous breakdown because I was interstate transporting...
“$130 million from scratch, that’s pretty good, but I think it’s underrepresented.” By Peter Callaghan, MinnPost Nearly a year into tax collections on Minnesota’s new lower-potency...
“The plaintiffs will be stuck in a regulatory limbo as of July 1, 2024.” By Clark Kauffman, Iowa Capital Dispatch A second group of companies is...
“Plaintiffs do not have a constitutional right to sell a controlled substance without obtaining a license. This point alone is fatal to plaintiffs’ case.” By Peter...
“I think that if so-and-so who got a license isn’t qualified to get a license, I should be able to point that out, go to a...
The report released last month by the comptroller’s office had incorrectly swapped data for two regions. By Bryan P. Sears, Maryland Matters The Office of the...
“I remain confident that Schedule III will happen and that it will survive judicial review under Loper Bright just as surely as it would have under...
“Bottom line: Absent Congressional action, the move to Schedule III just isn’t going to happen anytime soon.” By Deb Tharp, NuggMD The regulatory state has been...
“The program is focused on ensuring cannabis business licensing is fair, transparent and customer-service oriented.” By Sarah Ladd, Kentucky Lantern Kentuckians can now begin applying for...
“The Legislature’s passage of HB 1125 falls squarely within the police powers traditionally reserved to states.” By John Hult, South Dakota Searchlight A new law barring...